Aquilo Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,499,970
| Closed | -$17M | – | 16 |
|
|
2020
Q1 | $17M | Buy |
1,499,970
+333,234
| +29% | +$3.78M | 6.63% | 4 |
|
|
2019
Q4 | $15.3M | Buy |
1,166,736
+215,209
| +23% | +$2.82M | 5.75% | 4 |
|
|
2019
Q3 | $8.57M | Hold |
951,527
| – | – | 6.04% | 7 |
|
|
2019
Q2 | $9.38M | Hold |
951,527
| – | – | 3.26% | 7 |
|
|
2019
Q1 | $9.67M | Hold |
951,527
| – | – | 4.28% | 7 |
|
|
2018
Q4 | $6M | Buy |
951,527
+358,725
| +61% | +$2.26M | 2.91% | 8 |
|
|
2018
Q3 | $7.83M | Buy |
+592,802
| New | +$7.83M | 3.27% | 9 |
|